Hormonal Contraception Not Linked to Idiopathic Intracranial Hypertension Prevalence
Medically reviewed by Drugs.com
via HealthDayWEDNESDAY, March 25, 2026 -- Hormonal contraception (HC) is not associated with idiopathic intracranial hypertension (IIH) prevalence, according to a review published online March 25 in Neurology.
Andrew Mihalache, from the University of Toronto, and colleagues conducted a systematic review and meta-analysis to examine whether there is a meaningful association between HC use and IIH prevalence. Thirteen observational studies comparing HC use among women with IIH (5,351 women) and controls without IIH (669,260 women) were included.
The researchers observed no significant association for HC use with IIH prevalence. In subgroup analyses, no significant associations were seen for oral contraceptive pills, intrauterine devices, or medroxyprogesterone acetate injections. In sensitivity analyses, findings were largely robust. Quality assessments varied from poor to good, with very low to low certainty of evidence.
"Our findings can provide reassurance that using hormonal contraception may not be linked to this condition," coauthor Arun N.E. Sundaram, M.D., also from the University of Toronto, said in a statement. "However, it is important to note that the evidence is limited and large, well-designed studies are needed, particularly in diverse patient groups, to confirm these results."
One author disclosed ties to Invex Therapeutics, GenSight, and Ocular Therapeutix.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-26 08:59
Read more
- Want To Protect Your Brain? Science Says Exercise
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- Gap In Preventable Deaths Widening Between Those With, Without A College Degree
- Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
- ViiV Healthcare Reports Positive 12-Month Data Showing Investigational bNAb Lotivibart (N6LS) Maintains High Levels of Viral Suppression in Long-Acting HIV Treatment Regimen
- Recommendations Developed for Faltering Weight in Children
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions